Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Assets (2019 - 2025)

Historic Assets for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $1.3 billion.

  • CureVac's Assets rose 4189.62% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 4189.62%. This contributed to the annual value of $857.9 million for FY2024, which is 115.42% up from last year.
  • As of Q3 2025, CureVac's Assets stood at $1.3 billion, which was up 4189.62% from $779.8 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Assets ranged from a high of $2.2 billion in Q2 2021 and a low of $599.6 million during Q2 2024
  • Over the past 5 years, CureVac's median Assets value was $928.1 million (recorded in 2022), while the average stood at $1.1 billion.
  • In the last 5 years, CureVac's Assets surged by 16420927.79% in 2021 and then tumbled by 5445.24% in 2022.
  • CureVac's Assets (Quarter) stood at $1.3 billion in 2021, then crashed by 33.74% to $877.9 million in 2022, then fell by 3.39% to $848.1 million in 2023, then grew by 1.15% to $857.9 million in 2024, then soared by 55.16% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $779.8 million for Q2 2025, and $780.8 million during Q1 2025.